India · Delayed Price · Currency is INR Summit Materials Statistics
Total Valuation
Anuh Pharma has a market cap or net worth of INR 9.16 billion. The enterprise value is 8.53 billion.
| Market Cap | 9.16B |
| Enterprise Value | 8.53B |
Important Dates
The last earnings date was Friday, August 8, 2025.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | Aug 14, 2025 |
Share Statistics
Anuh Pharma has 100.22 million shares outstanding.
| Current Share Class | 100.22M |
| Shares Outstanding | 100.22M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.36% |
| Owned by Insiders (%) | 77.61% |
| Owned by Institutions (%) | n/a |
| Float | 22.14M |
Valuation Ratios
The trailing PE ratio is 19.84.
| PE Ratio | 19.84 |
| Forward PE | n/a |
| PS Ratio | 1.29 |
| PB Ratio | 2.81 |
| P/TBV Ratio | 2.81 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 18.49 |
| EV / Sales | 1.20 |
| EV / EBITDA | 13.77 |
| EV / EBIT | 15.89 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.18 |
| Debt / FCF | n/a |
| Interest Coverage | 77.95 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 10.64% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 24.06M |
| Profits Per Employee | 1.56M |
| Employee Count | 295 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Anuh Pharma has paid 135.48 million in taxes.
| Income Tax | 135.48M |
| Effective Tax Rate | 22.70% |
Stock Price Statistics
The stock price has decreased by -22.24% in the last 52 weeks. The beta is 0.26, so Anuh Pharma's price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | -22.24% |
| 50-Day Moving Average | 103.09 |
| 200-Day Moving Average | 96.78 |
| Relative Strength Index (RSI) | 33.59 |
| Average Volume (20 Days) | 57,711 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Anuh Pharma had revenue of INR 7.10 billion and earned 461.44 million in profits. Earnings per share was 4.60.
| Revenue | 7.10B |
| Gross Profit | 1.56B |
| Operating Income | 537.08M |
| Pretax Income | 596.92M |
| Net Income | 461.44M |
| EBITDA | 619.69M |
| EBIT | 537.08M |
| Earnings Per Share (EPS) | 4.60 |
Balance Sheet
The company has 734.15 million in cash and 108.86 million in debt, giving a net cash position of 625.29 million or 6.24 per share.
| Cash & Cash Equivalents | 734.15M |
| Total Debt | 108.86M |
| Net Cash | 625.29M |
| Net Cash Per Share | 6.24 |
| Equity (Book Value) | 3.26B |
| Book Value Per Share | 32.53 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 21.93%, with operating and profit margins of 7.57% and 6.50%.
| Gross Margin | 21.93% |
| Operating Margin | 7.57% |
| Pretax Margin | 8.41% |
| Profit Margin | 6.50% |
| EBITDA Margin | 8.73% |
| EBIT Margin | 7.57% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.75, which amounts to a dividend yield of 0.83%.
| Dividend Per Share | 0.75 |
| Dividend Yield | 0.83% |
| Dividend Growth (YoY) | 20.00% |
| Years of Dividend Growth | 4 |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 0.83% |
| Earnings Yield | 5.04% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 15, 2025. It was a forward split with a ratio of 2.
| Last Split Date | Jul 15, 2025 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |